These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 23990229)
21. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078 [TBL] [Abstract][Full Text] [Related]
22. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry. Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155 [TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of the SYNTAX score II in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of a four-year all-comers registry. Cid Alvarez AB; Gomez-Peña F; Redondo-Dieguez A; Avila A; López D; Sanmartin X; González-Juanatey JR; Trillo-Nouche R EuroIntervention; 2019 Oct; 15(9):e796-e803. PubMed ID: 30175963 [TBL] [Abstract][Full Text] [Related]
24. The TIMI risk score for STEMI predicts in-hospital mortality and adverse events in patients without cardiogenic shock undergoing primary angioplasty. González-Pacheco H; Arias-Mendoza A; Álvarez-Sangabriel A; Juárez-Herrera Ú; Damas F; Eid-Lidt G; Azar-Manzur F; Martínez-Sánchez C Arch Cardiol Mex; 2012; 82(1):7-13. PubMed ID: 22452860 [TBL] [Abstract][Full Text] [Related]
25. Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Akgul O; Baycan OF; Bulut U; Somuncu MU; Pusuroglu H; Ozyilmaz S; Gul M; Demir AR; Yılmaz E; Yazan S; Kokturk U; Cetin I; Uyarel H Coron Artery Dis; 2015 Nov; 26(7):592-7. PubMed ID: 26061437 [TBL] [Abstract][Full Text] [Related]
26. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
27. Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Pusuroglu H; Akgul O; Erturk M; Uyarel H; Bulut U; Akkaya E; Buturak A; Surgit O; Fuat A; Cetin M; Yldrm A Coron Artery Dis; 2014 Nov; 25(7):558-64. PubMed ID: 25004238 [TBL] [Abstract][Full Text] [Related]
28. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855 [TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of SYNTAX score after early percutaneous transluminal coronary angioplasty for acute ST elevation myocardial infarction. Yang CH; Hsieh MJ; Chen CC; Wang CY; Chang SH; Lee CH; Hsieh IC Heart Lung Circ; 2013 May; 22(5):341-5. PubMed ID: 23332234 [TBL] [Abstract][Full Text] [Related]
30. The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trial. Magro M; Räber L; Heg D; Taniwaki M; Kelbaek H; Ostojić M; Baumbach A; Tüller D; von Birgelen C; Roffi M; Pedrazzini G; Kornowski R; Weber K; Meier B; Lüscher TF; Serruys PW; Jüni P; Windecker S Int J Cardiol; 2014 Aug; 175(2):314-22. PubMed ID: 24882698 [TBL] [Abstract][Full Text] [Related]
31. Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice. Abelin AP; David RB; Gottschall CA; Quadros AS Can J Cardiol; 2014 Jan; 30(1):125-31. PubMed ID: 24238848 [TBL] [Abstract][Full Text] [Related]
32. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. Palmerini T; Genereux P; Caixeta A; Cristea E; Lansky A; Mehran R; Della Riva D; Fahy M; Xu K; Stone GW JACC Cardiovasc Interv; 2012 Nov; 5(11):1108-16. PubMed ID: 23174634 [TBL] [Abstract][Full Text] [Related]
33. Effect of serum gamma-glutamyl transferase levels on myocardial perfusion and long-term prognosis after primary angioplasty in patients with acute ST-elevation myocardial infarction. Ozcan F; Karakas MF; Ozlu MF; Akcay AB; Buyukkaya E; Kurt M; Erden G; Yuzgecer H; Yildirimkaya M; Hajro E; Balbay Y; Koc M; Yazici HU; Sen N J Investig Med; 2012 Dec; 60(8):1186-93. PubMed ID: 23076164 [TBL] [Abstract][Full Text] [Related]
34. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Tjandrawidjaja MC; Fu Y; Westerhout CM; Wagner GS; Granger CB; Armstrong PW; Am J Cardiol; 2010 Sep; 106(5):630-4. PubMed ID: 20723636 [TBL] [Abstract][Full Text] [Related]
36. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700 [TBL] [Abstract][Full Text] [Related]
37. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Bolińska S; Sobkowicz B; Zaniewska J; Chlebińska I; Boliński J; Milewski R; Tycińska A; Musiał W Kardiol Pol; 2011; 69(1):33-9. PubMed ID: 21267962 [TBL] [Abstract][Full Text] [Related]
38. Presence of early repolarization on admission electrocardiography is associated with long-term mortality and MACE in patients with STEMI undergoing primary percutaneous intervention. Ozcan KS; Güngör B; Tatlısu MA; Osmonov D; Ekmekçi A; Çalık AN; Aruğarslan E; Zengin A; Bolca O; Eren M; Erdinler İ J Cardiol; 2014 Sep; 64(3):164-70. PubMed ID: 24508178 [TBL] [Abstract][Full Text] [Related]
39. Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI. Kul S; Uyarel H; Kucukdagli OT; Turfan M; Vatankulu MA; Tasal A; Erdogan E; Asoglu E; Sahin M; Guvenc TS; Goktekin O Herz; 2015 Feb; 40(1):109-15. PubMed ID: 24609795 [TBL] [Abstract][Full Text] [Related]
40. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention. Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]